The clinical data management platform boosted its total funding to $30m in a Centene-led series B round featuring Optum Ventures.

Managed care provider Centene Corporation led an $18m series B round yesterday for Diameter Health, a US-based developer of data health optimisation software, to take its total funding to $30m.

The round included Optum Ventures, the corporate venturing vehicle for healthcare services provider Optum, as well as LRVHealth, Connecticut Innovations and Activate Venture Partners.

Diameter’s software converts raw healthcare data from clinical studies into interoperable data that can be analysed in depth by healthcare organisations. It will use the funding to broaden the types of data parsed by its Fusion platform and enhance its machine learning capabilities.

Mark Brooks, Centene’s chief information officer, said: “We invested in Diameter Health because their ability to automatically integrate and normalise clinical data will play an important role as we look to accelerate innovation and digitisation across our company.”

Optum Ventures had led Diameter’s $9.6m series A-1 round in April 2019, participating alongside existing investors Activate Venture Partners, Connecticut Innovations, LRVHealth and Excelerate Health Ventures.

Robert Lavine

Robert Lavine is special features editor for Global Venturing.